Navigation Links
AVEENO(R) Announces Kick-Off of The Skin Cancer Foundation's 2nd Annual 'Road to Healthy Skin' Tour Presented by AVEENO(R) and Rite Aid
Date:5/4/2009

Nationwide Tour Offers Free Skin Cancer Screenings And Education about Skin Cancer Prevention

SKILLMAN, N.J., May 4 /PRNewswire/ -- AVEENO(R), a brand of Johnson & Johnson Consumer Companies, Inc., announces its second year of sponsorship of The Skin Cancer Foundation's "Road to Healthy Skin" tour. The free skin cancer screening tour kicks off today at Pershing Square, just outside of New York City's Grand Central Terminal, and will visit more than 80 locations across the country through September 2009. The tour will offer free, full body skin cancer screenings in a private room inside a 38-foot customized RV, conducted by local board-certified dermatologists who have volunteered their time and expertise.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090504/NY10128 )

Last year the tour attracted almost 7,000 visitors and screened over 3,000 people. Of those screened, more than 3,200 suspicious markings were detected and 39 suspected cases of melanoma were discovered. "Skin cancer is still the most common form of cancer in the United States, but it is also the most preventable and curable form of cancer if it is detected early," says dermatologist Jeanine Downie, MD. "We are proud of the amount of people we screened last year and that we identified over 900 potential skin cancers with 39 of them potentially being the most deadly form - melanoma. We hope to see an increase in the practice of preventative measures so that we can soon report a decrease in the number of new cases of skin cancer as a result of these tours."

According to The Skin Cancer Foundation, there are more cases of skin cancer than the combined incidence of cancers of the breast, prostate, lung and colon; in fact, one in five American
'/>"/>

SOURCE AVEENO(R)
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. AVEENO(R) Announces Sponsorship and Kick-Off of The Skin Cancer Foundations Road to Healthy Skin Tour Presented by AVEENO(R) and Rite Aid
2. Sarnova Announces Acquisition to Expand Bound Tree Medical Business
3. Inverness Medical Innovations, Inc. Announces Offering of $200 Million of Senior Subordinated Notes
4. Healthy Living Network Announces Launch of New Blood Sugar Web Site
5. Governor Rendell Announces Pennsylvanias First Confirmed Case of 2009 A/H1N1 Flu
6. Triple-S Management Corporation Announces Execution of Definitive Agreement to Acquire Managed Care Portfolio of La Cruz Azul de Puerto Rico, Inc.
7. American Academy of Orthopaedic Surgeons Announces Media Orthopaedic Reporting Excellence (MORE) Award Winners
8. IBM Announces New Healthcare Industry Solutions Lab in China
9. VIA Pharmaceuticals Announces Positive Phase 2 Results of VIA-2291 in Cardiovascular Patients Using Serial MDCT Imaging of Coronary Plaque
10. HMS Holdings Corp. Announces First Quarter 2009 Financial Results
11. Healthy Living Network Announces Launch of New Supplement Information Web Site
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 2Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 3Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 4Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 5Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 6Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6Daniel K. Spiegelman Elected to Board of Directors of Omeros 2The Presidents Council on Physical Fitness and Sports Announces 2009 Lifetime Achievement Award Winners 49257 1The Presidents Council on Physical Fitness and Sports Announces 2009 Lifetime Achievement Award Winners 49257 2The Presidents Council on Physical Fitness and Sports Announces 2009 Lifetime Achievement Award Winners 49257 3Texas Institute for Surgery at Presbyterian Hospital of Dallas Introduces the First Wireless OR in DFW 49253 1Texas Institute for Surgery at Presbyterian Hospital of Dallas Introduces the First Wireless OR in DFW 49253 234 Outstanding Teachers and Schools Receive 2410 000 Amgen Award for Science Teaching Excellence 49248 134 Outstanding Teachers and Schools Receive 2410 000 Amgen Award for Science Teaching Excellence 49248 234 Outstanding Teachers and Schools Receive 2410 000 Amgen Award for Science Teaching Excellence 49248 334 Outstanding Teachers and Schools Receive 2410 000 Amgen Award for Science Teaching Excellence 49248 4